Company / Working Capital
BIOTRICITY INC. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$16.0M
FY2025
5-year range
-$18.2M / $10.5M
FY2021-FY2025
Trend
+12.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital returned to growth in FY2025 after 2 years of decline, reaching -$16M.
Based on SEC 10-K filings.
-$16M in FY2025.
Declined from -$6M to -$16M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital increased 12.2% year-over-year.
- Peak working capital was recorded in FY2022.
- Lowest working capital in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -22.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$16.0M | +12.2% |
| FY2024 | -$18.2M | -183.0% |
| FY2023 | -$6.4M | -161.6% |
| FY2022 | $10.5M | +269.5% |
| FY2021 | -$6.2M | -187.7% |
| FY2020 | -$2.1M | -18.4% |
| FY2019 | -$1.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026